Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell Huby

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|August 23, 2006
Gene expression profiling for pharmaceutical safety assessmentRussell Huby, Jonathan D Tugwood
Toxicology|December 14, 2004
Gene expression changes induced by estrogen and selective estrogen receptor modulators in primary-cultured human endometrial cells: signals that distinguish the human carcinogen tamoxifenJessica C M Pole, Leslie I Gold, Terry Orton, et al.
Toxicologic Pathology|July 24, 2008
Early stellate cell activation and veno-occlusive-disease (VOD)-like hepatotoxicity in dogs treated with AR-H047108, an imidazopyridine proton pump inhibitorAnna-Lena Berg, Gerhard Böttcher, Kjell Andersson, et al.
Environmental Science & Technology|January 10, 2017
Bioavailability and Kidney Responses to Diclofenac in the Fathead Minnow (Pimephales promelas)Lisa K Bickley, Ronny van Aerle, A Ross Brown, et al.
Basic & Clinical Pharmacology & Toxicology|June 30, 2012
Inhibition of oestradiol-induced prolactin release in a dual-cannulated ovariectomized rat model by carmoxirole, a peripherally restricted dopamine agonistDavid A Brott, Jennifer L Werkheiser, Pam Campbell, et al.
Cell Metabolism|December 3, 2015
Leptin, BMI, and a Metabolic Gene Expression Signature Associated with Clinical Outcome to VEGF Inhibition in Colorectal CancerAurélien J C Pommier, Matthew Farren, Bhavika Patel, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Metabolism & Toxicology|August 23, 2006
Gene expression profiling for pharmaceutical safety assessmentRussell Huby, Jonathan D Tugwood
Toxicology|December 14, 2004
Gene expression changes induced by estrogen and selective estrogen receptor modulators in primary-cultured human endometrial cells: signals that distinguish the human carcinogen tamoxifenJessica C M Pole, Leslie I Gold, Terry Orton, et al.
Toxicologic Pathology|July 24, 2008
Early stellate cell activation and veno-occlusive-disease (VOD)-like hepatotoxicity in dogs treated with AR-H047108, an imidazopyridine proton pump inhibitorAnna-Lena Berg, Gerhard Böttcher, Kjell Andersson, et al.
Environmental Science & Technology|January 10, 2017
Bioavailability and Kidney Responses to Diclofenac in the Fathead Minnow (Pimephales promelas)Lisa K Bickley, Ronny van Aerle, A Ross Brown, et al.
Basic & Clinical Pharmacology & Toxicology|June 30, 2012
Inhibition of oestradiol-induced prolactin release in a dual-cannulated ovariectomized rat model by carmoxirole, a peripherally restricted dopamine agonistDavid A Brott, Jennifer L Werkheiser, Pam Campbell, et al.
Cell Metabolism|December 3, 2015
Leptin, BMI, and a Metabolic Gene Expression Signature Associated with Clinical Outcome to VEGF Inhibition in Colorectal CancerAurélien J C Pommier, Matthew Farren, Bhavika Patel, et al.
Pageof 1